A. Abbate

MHC class II invariant chain–adjuvanted viral vectored vaccines enhances T cell responses in humans

A. Folgori, A. Nicosia, P. Klenerman, 2020, Science Translational Medicine.

Fusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates.

A. Folgori, R. Cortese, A. Nicosia, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite Instability

A. Folgori, A. Nicosia, F. Mori, 2020, Cancer Research.

CBX7 is a tumor suppressor in mice and humans

A. Fusco, G. Palma, C. Arra, 2012 .

CBX7 is a tumor suppressor in mice and humans.

A. Fusco, G. Palma, C. Arra, 2012, The Journal of clinical investigation.

Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

Mario Roederer, Richard A Koup, Lisa Hensley, 2014, Nature Medicine.

A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C

A. Folgori, A. Nicosia, J. Ball, 2020, PLoS neglected tropical diseases.

Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates

A. Folgori, R. Cortese, A. Nicosia, 2015, Molecular therapy. Methods & clinical development.

Correction: A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C

A. Folgori, A. Nicosia, J. Ball, 2021, PLoS neglected tropical diseases.